ArticleJournal of gastrointestinal oncology2024

Efficacy and safety of transarterial chemoembolization alone compared to its combination with anlotinib among patients with intermediate or advanced stage hepatocellular carcinoma: a phase II randomized controlled trial.

Dinghu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.